Top compounds associated with response to RGPD5


Feature Type Standardized
Nominal ANOVA
mRNA ibrutinib CTRPv2 pan-cancer AAC -0.16 0.0004
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.14 0.0005
mRNA CAL-101 CTRPv2 pan-cancer AAC -0.13 0.001
mRNA lapatinib CTRPv2 pan-cancer AAC -0.13 0.002
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.002
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA Bosutinib CTRPv2 pan-cancer AAC -0.11 0.003
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.003
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.18 0.004
mRNA elocalcitol CTRPv2 pan-cancer AAC -0.11 0.004
Download CSV